Diagnostic yield of MRI of the brain and IAC in patients with neurotologic complaints
K Robinette, B Benscoter, G Trenkle, S Alapati… - American Journal of …, 2018
… Demographics, clinical history, physical examination, and audiometric findings
were used to categorize new patients into 7 groups: definite Meniere's disease
(MD), probable MD, possible MD, vague dizziness, tinnitus only, asymmetric …
were used to categorize new patients into 7 groups: definite Meniere's disease
(MD), probable MD, possible MD, vague dizziness, tinnitus only, asymmetric …
 |  |  |
Hyperglycemia and diabetes mellitus are related to vestibular organs dysfunction: truth or suggestion? A literature review
FM Gioacchini, R Albera, M Re, A Scarpa… - Acta Diabetologica, 2018
… still understood. Moreover it is not defined the possible role of these two blood
conditions in worsening the prognosis of typical vestibular pathologies like "benign
paroxysmal positional vertigo" and "Meniere disease". The aim …
conditions in worsening the prognosis of typical vestibular pathologies like "benign
paroxysmal positional vertigo" and "Meniere disease". The aim …
| | |
[HTML] Tinnitus in patients with hearing loss due to mitochondrial DNA pathogenic variants
U Lechowicz, A Pollak, D Raj-Koziak, B Dziendziel… - European Archives of Oto …, 2018
… Auditory hallucinations can be constant or inter- mittent with localization in
one, both ears or within the head and may have different age of onset
[1–4]. The etiology of tinnitus is broad and encompasses aging, hearing loss …
one, both ears or within the head and may have different age of onset
[1–4]. The etiology of tinnitus is broad and encompasses aging, hearing loss …
| | |
[HTML] Different clinical presentation of intralabyrinthine schwannomas–a systematic review
TGA Elias, AP Neto, ATS Zica, ML Antunes… - Brazilian Journal of …, 2018
… Moreover, the clinical picture may suggest other more frequent diagnoses, which include
Meniere's disease, vestibular neuritis or sudden idiopathic hearing loss. 10 In our review,
we found a total of 526 reported cases of intralabyrinthine schwannoma …
Meniere's disease, vestibular neuritis or sudden idiopathic hearing loss. 10 In our review,
we found a total of 526 reported cases of intralabyrinthine schwannoma …
| | |
The effect of cochlear implants on vestibular-evoked myogenic potential responses and postural stability
T Miwa, R Minoda, H Matsuyoshi, H Takeda - Auris Nasus Larynx, 2018
Current spread by electrical stimulation via inserted cochlear implant (CI) electrodes and
the consequential increase in sound input can affect the equilibrium.
the consequential increase in sound input can affect the equilibrium.
| | |
SIRP POLYPEPTIDE COMPOSITIONS AND METHODS OF USE
AM Ring, RL Maute, AC Kruse, A Manglik, KS Lin - US Patent App. 15/814,337, 2018
Provided herein are SIRP-gamma, SIRP-beta or SIRP-beta2 decoy
polypeptides for immunotherapy and/or treatment of cancer, anemia, transplant,
asthma, allergy, auto-immune disease, and viral infection.
polypeptides for immunotherapy and/or treatment of cancer, anemia, transplant,
asthma, allergy, auto-immune disease, and viral infection.
| | |
Heterocyclic Compound
T Kamei, Y Arikawa, T Ohashi, T Imaeda, I Fujimori… - US Patent App. 15/568,644, 2018
The present invention provide a compound having an orexin receptor
antagonistic activity, which is expected to be useful as medicaments such
as agents for the prophylaxis or treatment of sleep disorde.
antagonistic activity, which is expected to be useful as medicaments such
as agents for the prophylaxis or treatment of sleep disorde.
| | |
ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF
SK KC, CC Mak, BW Eastman, J Cao, V Bollu… - US Patent App. 15/884,112, 2018
Isoquinoline compounds for treating various diseases and pathologies are
disclosed. More particularly, the present invention concerns the use of an
isoquinoline compound or analogs thereof, in the tre.
disclosed. More particularly, the present invention concerns the use of an
isoquinoline compound or analogs thereof, in the tre.
| | |
STEROIDS AND PROTEIN-CONJUGATES THEREOF
A Han, AJ Murphy, W Olson - US Patent App. 15/806,197, 2018
Described herein protein steroid conjugates that are useful, for example, for
the target-specific delivery of glucocorticoids (GCs) to cells.
the target-specific delivery of glucocorticoids (GCs) to cells.
| | |
ANTIBODY MOLECULES TO PD-1 AND USES THEREOF
GJ Freeman, AH Sharpe, WA Blattler, JM Mataraza… - US Patent App. 15/727,456, 2018
Antibody molecules that specifically bind to PD-1 are disclosed. The
anti-PD-1 antibody molecules can be used to treat, prevent and/or
diagnose cancerous or infectious conditions and disorders.
anti-PD-1 antibody molecules can be used to treat, prevent and/or
diagnose cancerous or infectious conditions and disorders.
| | |
Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου